Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats

Figure 4

Effects of alagebrium (10 mg/kg), perindopril (4 mg/kg), or gliclazide (10 mg/kg) on (a) brain catalase activity, (b) brain GSH content, and (c) brain MDA content in STZ-induced diabetes in rats. Data are presented as mean ± SEM (). Significantly different from control group. Significantly different from diabetic group at using ANOVA followed by Tukey’s post hoc test.

(a)

(b)

(c)